Centrum 7/6  banner

USP to its current portfolio.

Camber launches generic Zetia

Camber launches generic Zetia

PISCATAWAY, N.J. — Camber Pharmaceuticals nnounces the addition of ezetimibe tablets, USP to its current portfolio. Ezetimibe tablets, USP are an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet to: Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA

Camber Pharmaceuticals launches generic Toradol

Camber Pharmaceuticals launches generic Toradol

PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of ketorolac tromethamine tablets, USP to its current portfolio. Ketorolac tromethamine tablets are indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with

Camber launches generic Thyro-Tabs

Camber launches generic Thyro-Tabs

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of levothyroxine sodium tablets, USP to its current portfolio. Levothyroxine sodium tablets, USP are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism, and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated

Camber launches generic Vimpat Injection

Camber launches generic Vimpat Injection

PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of Lacosamide Injection, USP to its current portfolio. Lacosamide Injection is indicated for treatment of partial-onset seizures in patients 17 years of age and older. Camber’s 200 mg/20 mL (10 mg/mL) strength of Lacosamide Injections is available in a 10 pack of single-dose vials. To find out

PP_1170x120_10-25-21